Home

Omega Fund V GP, L.P.

CIK 1641355 · last filed 2022-04-07

Omega Fund V GP, L.P. is a corporate insider who has filed 13 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $42.0M of NUVB.WS on Apr 7, 2022. Across all open-market trades the lifetime net is −$128.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions. The firm reports its address in Boston, MA. 61 SEC filings were submitted jointly with Omega Fund V GP Manager, Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.22M

Companies

3

Total Filings

13

Lifetime Open-Market Net

-$128.64M

Filer Profile

Reported Address
888 BOYLSTON ST., SUITE 1111
BOSTON, MA 02199
Phone
(617) 502-6538
State of Incorporation
Cayman Islands
Related Filers
Omega Fund V GP Manager, Ltd. — 61 joint filings, latest 2022-04-07
Omega Fund V, L.P. — 61 joint filings, latest 2022-04-07
Otello Stampacchia — 53 joint filings, latest 2021-05-03
Claudio Nessi — 9 joint filings, latest 2021-02-12
Anne-Mari Paster — 9 joint filings, latest 2021-02-12
Richard J. Lim — 5 joint filings, latest 2019-07-01
Anna Guyer Mitsak — 2 joint filings, latest 2019-05-13
Omega Fund IV G.P. Manager, Ltd. — 2 joint filings, latest 2018-07-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Nuvation Bio Inc. (NUVB.WS) Delisted 10%+ Owner 20,457,340 $0.01 $104.3K -$83.16M 3 2022-04-07
Morphic Holding, Inc. (MORF) Delisted Director 2,071,768 $56.99 $118.07M -$43.63M 9 2021-05-03
GOSS 10%+ Owner 6,932,012 $0.18 $1.22M -$1.85M 1 2019-09-09

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-04-07 Nuvation Bio Inc. (NUVB.WS) Delisted Sell (S) −7,500,000 -$42.00M EDGAR
2021-12-09 Nuvation Bio Inc. (NUVB.WS) Delisted Sell (S) −4,200,000 -$41.16M EDGAR
2021-05-03 Morphic Holding, Inc. (MORF) Delisted Sell (S) −68,632 -$3.75M EDGAR
2021-04-27 Morphic Holding, Inc. (MORF) Delisted Sell (S) −55,272 -$3.10M EDGAR
2021-04-15 Morphic Holding, Inc. (MORF) Delisted Sell (S) −83,744 -$4.81M EDGAR
2021-04-13 Morphic Holding, Inc. (MORF) Delisted Sell (S) −99,248 -$5.76M EDGAR
2021-04-02 Morphic Holding, Inc. (MORF) Delisted Sell (S) −121,620 -$7.78M EDGAR
2021-03-29 Morphic Holding, Inc. (MORF) Delisted Sell (S) −191,748 -$11.25M EDGAR
2021-02-12 Nuvation Bio Inc. (NUVB.WS) Delisted Mixed +60,410,679 $35.00M EDGAR
2021-01-29 Morphic Holding, Inc. (MORF) Delisted Sell (S) −82,944 -$2.72M EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.